132-137
Placental pathologies and fetal outcome in pregnant women with COVID-19: A retrospective study
Authors: Soheila Sarmadi, Ara Omranipour, Elham Mirzaian, Roghayyeh Ahangari, Zahra Yazdi, Azadeh Asgarian, Monireh Mirzaie
Number of views: 100
Objective: To describe histopathologic findings in the placentas
in women with coronavirus disease 2019 (COVID-19) during
pregnancy.
Methods: In a cross-sectional study, 38 pregnant women with
COVID-19 and undergoing delivery between March 2020
and January 2022, were included. The patients had positive
polymerase chain reaction (PCR) test for SARS-CoV-2 infection
and the placentas after delivery were sent for histopathologic
evaluation based on the Amsterdam Placental Workshop Group
Consensus Statement and assessed by two pathologists.
Results: Our results showed that maternal vascular malperfusion
was the most common and was present in 17 cases (44.7%).
These features included accelerated villous maturation (36.8%)
distal villous hypoplasia (5.3%), placental infarction (5.3%) and
intervillous fibrin deposition (10.5%). Other pathologic findings
included focal calcification (10.5%), intravillous congestion and
hemorrhage (10.5%), sub-chorionic hemorrhage (5.3%), acute
villitis, chronic histiocytic intervillositis and delayed villous
maturation each in one case (2.6%). Twelve out of 38 cases showed
no significant pathologic changes. Fetal outcomes included neonatal
intensive care unit admission rate of 13.2%, dyspnea 31.6%,
newborn’s anosmia 7.9%, intrauterine fetal demise 2.6%, asphyxia
2.6% and neonate COVID infection 5.3%.
Conclusions: Microvasculopathy, as a sign of maternal vascular
malperfusion, is a common finding in placentas from SARS-CoV-2
positive pregnant women in the present study. Further studies with
larger sample sizes and comparative studies between COVID-19
positive and negative, as well as information from patient follow-up
are suggested.